Figure 2
From: Chromosomal imbalance in the progression of high-risk non-muscle invasive bladder cancer
The fraction of the genome altered (FGA) against the clinical course (progression/no progression), separately for copy number changes (left) and LOH (right). Non-progressing tumors in triangles, progressing in diamonds. Solid symbols indicate stage T1 tumors. Ranksum-tests for difference in FGA between progressing and non-progressing tumors for all tumors (n = 48) and for stage T1 tumors only (n = 33) showed no significant difference. Here, the relative size of the FGA, not the influence of the time to progression is analysed.